期刊
MOLECULAR CANCER
卷 19, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s12943-020-1144-6
关键词
Cancer immunotherapy; Immune checkpoint blockade; PD-1; PD-L1; Immune cells; Precision medicine
资金
- National Natural Science Foundation of China [81672683, 81672993, 81772928, 81872278, 81972776]
- Overseas Expertise Introduction Project for Discipline Innovation (111 Project) [111-2-12]
- Natural Science Foundation of Hunan Province [2017SK2105, 2018SK21210, 2018SK21211]
Immune checkpoint blockade targeting PD-1/PD-L1 has promising therapeutic efficacy in a variety of tumors, but resistance during treatment is a major issue. In this review, we describe the utility of PD-L1 expression levels, mutation burden, immune cell infiltration, and immune cell function for predicting the efficacy of PD-1/PD-L1 blockade therapy. Furthermore, we explore the mechanisms underlying immunotherapy resistance caused by PD-L1 expression on tumor cells, T cell dysfunction, and T cell exhaustion. Based on these mechanisms, we propose combination therapeutic strategies. We emphasize the importance of patient-specific treatment plans to reduce the economic burden and prolong the life of patients. The predictive indicators, resistance mechanisms, and combination therapies described in this review provide a basis for improved precision medicine.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据